A Study of SBT6050 Alone and in Combination With PD-1 Inhibitors in Subjects With Advanced HER2 Expressing Solid Tumors
Clinical trial NCT04460456 · UNKNOWN
Trial details
- NCT number
- NCT04460456
- Sponsor
- Silverback Therapeutics
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-27
- Primary completion
- 2022-12-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.